What exactly changed in the CN analyst rating on March 13, 2026?

On March 13, 2026 Raymond James downgraded CN from **Strong Buy** to **Market Perform** at 08:37 AM, while KeyBanc maintained **Overweight** at 08:47 AM. Both notes lacked public price targets.

How should investors interpret the CN downgrade by Raymond James?

The downgrade signals reduced near-term upside from Raymond James rather than a sell recommendation. Investors should view this as lower conviction, and weigh it against other coverage, ETF flows, and China macro factors before reallocating.

Does the KeyBanc maintain mean CN is a buy now?

KeyBanc's Overweight maintain shows continued preference for CN exposure but is not a fresh buy signal. Investors should combine this view with their risk tolerance, NAV and fee considerations, and broader China allocation plans.

Are there new CN price targets from these analyst notes?

No. Neither the Raymond James downgrade nor the KeyBanc maintain published a CN price target in the March 13, 2026 notes referenced in StreetInsider, so valuation guidance is absent.

Analyst Ratings

CN Xtrackers MSCI All China Equity ETF KeyBanc Maintains Overweight Mar 2026

ByHuzaifa Zahoor March 16, 2026March 16, 2026

Raymond James downgraded CN (Xtrackers MSCI All China Equity ETF) from Strong Buy → Market Perform on March 13, 2026, the headline move that sets the tone for the day. The same morning KeyBanc kept CN at Overweight on March 13, 2026, so this mixed set of views drives the current CN analyst rating debate. Investors see a shift in conviction from one large shop and confirmation from another, with no public price targets disclosed in the filings. We break down each action, the implications, and historical coverage to help investors weigh the signals.